M. TAŞDEMİR Et Al. , "Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study," 51st Annual Meeting of European Society for Paediatric Nephrology , 2018
TAŞDEMİR, M. Et Al. 2018. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study. 51st Annual Meeting of European Society for Paediatric Nephrology .
TAŞDEMİR, M., CANPOLAT, N., YILDIZ, N., ÖZÇELİK, G., BENZER, M., SAYGILI, S. K., ... ÖZKAYIN, E. N.(2018). Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study . 51st Annual Meeting of European Society for Paediatric Nephrology
TAŞDEMİR, MEHMET Et Al. "Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study," 51st Annual Meeting of European Society for Paediatric Nephrology, 2018
TAŞDEMİR, MEHMET Et Al. "Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study." 51st Annual Meeting of European Society for Paediatric Nephrology , 2018
TAŞDEMİR, M. Et Al. (2018) . "Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study." 51st Annual Meeting of European Society for Paediatric Nephrology .
@conferencepaper{conferencepaper, author={MEHMET TAŞDEMİR Et Al. }, title={Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter study}, congress name={51st Annual Meeting of European Society for Paediatric Nephrology}, city={}, country={}, year={2018}}